Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. (ENSC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ENSC · as of Jun 30, 2024
Ownership Breakdown
1
Institutional Holders
$10
Total Inst. Value
▼ $6 vs Q1
9.28M
Shares Outstanding
freeFloat 99.89%
20
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ENSC largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PLANTE MORAN FINANCIAL ADVISORS, LLC pharmaceutical preparations | 20 | 0.04% | 0.04% | $10,000 | Aug 12, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ENSC insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
GOWER BOB G director | Mar 2, 2023 | Purchase | 90,287 | $0.49 | $44.1K | 1.22M | Form 4 ↗ |
GOWER BOB G director | Mar 1, 2023 | Purchase | 270,000 | $0.48 | $129.0K | 1.13M | Form 4 ↗ |
GOWER BOB G director | Feb 28, 2023 | Purchase | 109,300 | $0.49 | $53.4K | 862.4K | Form 4 ↗ |
GOWER BOB G director | Dec 9, 2022 | Purchase | 357,143 | $1.40 | $500.0K | 753.1K | Form 4 ↗ |
GOWER BOB G director | Dec 9, 2022 | Award | 714,286 | $1.40 | $1.00M | 716.4K | Form 4 ↗ |
Chang William H
| Jun 23, 2022 | Award | 15,000 | — | — | 35.0K | Form 4 ↗ |
Martin Steven Robert
| Jun 23, 2022 | Award | 15,000 | — | — | 100.8K | Form 4 ↗ |
Rauch Lee M.
| Jun 23, 2022 | Award | 15,000 | — | — | 35.0K | Form 4 ↗ |
GOWER BOB G
| Jun 23, 2022 | Award | 15,000 | $0.42 | $6.4K | 41.6K | Form 4 ↗ |
GOWER BOB G
| Jun 23, 2022 | Award | 15,000 | — | — | 41.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ensysce Biosciences, Inc. (ENSC) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.11%, while retail and public investors account for the remaining 99.89%.
The largest institutional shareholder of Ensysce Biosciences, Inc. is PLANTE MORAN FINANCIAL ADVISORS, LLC, holding approximately 20 shares — equal to 0.04% of outstanding shares — as of June 30, 2024.
A total of 1 institutional investors currently hold ENSC stock, with a combined institutional value of approximately $10 as of the most recent 13F filing period.
Frequently asked questions
ENSC ownershipEnsysce Biosciences, Inc. (ENSC) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is PLANTE MORAN FINANCIAL ADVISORS, LLC with a 0.04% stake. Company insiders hold 0.11%. Data sourced from SEC Form 13F as of June 30, 2024.